Moderna’s mRNA Vaccine for Lung and Melanoma Cancer: Phase 3 Trials and Accelerated Approvals – Latest News and Updates
2023-12-14 19:58:40 The company also announced Monday the start of a “phase 3” trial for an mRNA vaccine against lung cancer and is studying other types of tumors. Moderna CEO Stéphane Bancel told AFP that his company’s experimental melanoma vaccine could be available in just two years, marking a historic step against the most serious … Read more